Shahar Cohen, CTO at Verix
In a world full of options, companies need to compete on every prospect and existing customer. As the number of potential channels to reach customers increases, companies need to build…
Continue Reading
What You Should Know:
– The pharmaceutical and life sciences (PLS) sector is experiencing a resurgence in dealmaking activity, with a 20% increase in deal volume over the past year reported, according to PwC’s latest…
Continue Reading
What You Should Know:
– Vultr, the world’s largest, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training,…
Continue Reading
Oncology-focused digital therapeutics company Mika Health announced a partnership with pharma companies AstraZeneca and Daiichi Sankyo for an initiative dubbed “UNITE” to provide digital therapeutics to women undergoing breast cancer treatments. Mika Health’s app gives…
Continue Reading
What You Should Know:
– Salesforce announced the general availability of Life Sciences Cloud, a platform for pharmaceutical (pharma) and medical technology (medtech) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline…
Continue Reading
Dr. Elizabeth Reed Aden, a PHD and a former pharma industry executive and the author of The Goldilock Genome joins eHealth Radio and the Health News and Pharmaceutical Channels.
Listen to interview with host Eric…
Telstra Health is set to fully acquire pharmacy IT solutions provider Fred IT Group. The company, which has been holding 50% interest in Fred IT since 2013, disclosed in a media release that it will…
Continue Reading
In the search for faster and more effective medicines, the integration of artificial intelligence (AI) can positively impact millions of lives. AI is transforming the foundations of biotech, promising to alter precision medicine, clinical…
Continue Reading
What You Should Know:
– Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration. The first-of-its-kind partnership…
Continue Reading
Here’s part 2 of MedCity News’ Q&A with Astellas Pharma CEO Naoki Okamura who was in South San Francisco last week for the opening of the Japanese pharma company’s West Coast Innovation Center. You…
Continue Reading
